From: Prophylaxis in older Canadian adults with hemophilia A: lessons and more questions
18-39 years | ≥40 years | p value | |
---|---|---|---|
Number, % | 160 (73) | 60 (27) | - |
Median age (IQR), yrs | 26.8 (21.9;32.4) | 48.3 (43.7;52.6) | - |
Baseline FVIII:C, no. (%) | |||
<1% | 119 (74) | 46 (77) | NS |
1% | 25 (16) | 10 (17) | NS |
2% | 16 (10) | 4 (6) | NS |
Time records available | |||
Median (IQR), yrs | 11.2 (4;19) | 18.7 (11.1;28.8) | <0.001 |
Range, yrs | 0.5-38 | 0.5-48 | |
Inhibitor status no. (%) 1 | |||
Historical* | 23 (15) | 15 (25) | NS |
Current | 2 (1) | 6 (10) | 0.002 |
Joints affected, median no. (%) | |||
0-1 | 79 (49) | 15 (25) | <0.001 |
2-4 | 73 (46) | 31 (52) | <0.001 |
>4 | 8 (5) | 14 (23) | <0.001 |
Prior Joint procedures, no. | |||
Median | 0 (0;1) | 1 (0;3) | <0.001 |
Range | 0-4 | 0-8 | |
Co-infections, no. (%) | |||
HIV | 40 (25) | 35 (58) | <0.001 |
HCV Ab | 89 (56) | 48 (80) | 0.001 |
HCV RNA+ | 50 (31) | 31 (52) | 0.005 |
HIV + HCV Ab | 36 (23) | 29 (48) | <0.001 |
HIV + HCV RNA+ | 27 (17) | 22 (37) | 0.002 |
HBSAg + | 11 (7) | 4 (7) | NS |
Median weight (IQR), kg | 79.5 (69.5;88.5) | 71.5 (63.5;79) | 0.002 |